None listed
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Dr Vignesh J
Eligibility
Inclusion criteria
Inclusion criteria: Participants aged 20 40 years, who are healthy individuals and have been residing in a metropolitan city for a minimum duration of 2 months.
Exclusion criteria
Exclusion criteria: 1.Pregnant and lactating women. 2.Suffering from any acute or chronic health condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative change in Nrf2 gene expression (mRNA levels) before and after Virechana therapy, expressed as fold change using qPCR analysis.Timepoint: Outcome measures will be assessed at two timepoints, baseline (prior to Virechana) and post-intervention (11th or 13th day after completion of therapy) to evaluate the genomic impact of Virechana. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quantitative changes in downstream antioxidant genes HO-1, NQO1, and GST before and after Virechana, indicating activation of the Nrf2-ARE pathway.Timepoint: Outcome measures will be assessed at two timepoints: baseline (prior to Virechana) and post-intervention (11th or 13th day after completion of therapy) to evaluate the genomic and physiological impact of Virechana. | — |
Countries
India
Contacts
Public ContactDr Vignesh J
Government Ayurveda Medical College
Outcome results
None listed